Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses
- PMID: 26658375
- PMCID: PMC5218633
- DOI: 10.1097/INF.0000000000001006
Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses
Abstract
Background: Few studies have examined the effectiveness of full versus partial vaccination with inactivated trivalent influenza vaccines (IIV3) as defined by the US CDC Advisory Committee on Immunization Practices.
Methods: Respiratory swabs were collected from outpatients aged 6 months to 8 years with acute cough for ≤7 days in clinics in 5 states during the 2011-2012 and 2012-2013 influenza seasons. Influenza was confirmed by real-time reverse transcription polymerase chain reaction assay. Receipt of current season IIV3 and up to 4 prior vaccinations was documented from medical records and immunization registries. Using a test-negative design, vaccine effectiveness (VE) was estimated adjusting for age, race/ethnicity, medical conditions, study site and month of enrollment.
Results: We did not observe higher VE for children fully versus partially vaccinated with IIV3, as defined by US Advisory Committee on Immunization Practice, although our sample of partially vaccinated children was relatively small. However, among children aged 2-8 years in both seasons and against A(H3N2) and B influenza illness separately, VE point estimates were consistently higher for children who had received 2 doses in the same prior season compared with those without (VE range of 58%-80% vs. 33%-44%, respectively). Across seasons, the odds of A(H3N2) illness despite IIV3 vaccination were 2.4-fold (95% confidence interval: 1.4-4.3) higher among children who had not received 2 doses in the same prior season. We also noted residual protection among unvaccinated children who were vaccinated the previous season (VE range = 36%-40% across outcomes).
Conclusion: Vaccination with IIV3 may provide preventive benefit in subsequent seasons, including possible residual protection if vaccination is missed. Two vaccine doses in the same season may be more effective than alternative priming strategies.
Similar articles
-
Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.JAMA Pediatr. 2020 Jul 1;174(7):705-713. doi: 10.1001/jamapediatrics.2020.0372. JAMA Pediatr. 2020. PMID: 32364599 Free PMC article.
-
Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.JAMA Netw Open. 2018 Oct 5;1(6):e183742. doi: 10.1001/jamanetworkopen.2018.3742. JAMA Netw Open. 2018. PMID: 30646262 Free PMC article.
-
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016.Influenza Other Respir Viruses. 2020 Jul;14(4):380-390. doi: 10.1111/irv.12741. Epub 2020 Apr 16. Influenza Other Respir Viruses. 2020. PMID: 32298048 Free PMC article.
-
Influenza and Influenza Vaccine: A Review.J Midwifery Womens Health. 2021 Jan;66(1):45-53. doi: 10.1111/jmwh.13203. Epub 2021 Feb 1. J Midwifery Womens Health. 2021. PMID: 33522695 Free PMC article. Review.
-
Challenges in estimating influenza vaccine effectiveness.Expert Rev Vaccines. 2019 Jun;18(6):615-628. doi: 10.1080/14760584.2019.1622419. Epub 2019 May 31. Expert Rev Vaccines. 2019. PMID: 31116070 Free PMC article. Review.
Cited by
-
Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis.Lancet Respir Med. 2023 Jan;11(1):27-44. doi: 10.1016/S2213-2600(22)00266-1. Epub 2022 Sep 21. Lancet Respir Med. 2023. PMID: 36152673 Free PMC article.
-
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India.Hum Vaccin Immunother. 2022 Nov 30;18(6):2104527. doi: 10.1080/21645515.2022.2104527. Epub 2022 Sep 2. Hum Vaccin Immunother. 2022. PMID: 36053721 Free PMC article. Clinical Trial.
-
Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season.PLoS One. 2021 Mar 26;16(3):e0249005. doi: 10.1371/journal.pone.0249005. eCollection 2021. PLoS One. 2021. PMID: 33770132 Free PMC article.
-
Estimates of Inactivated Influenza Vaccine Effectiveness Among Children in Senegal: Results From 2 Consecutive Cluster-Randomized Controlled Trials in 2010 and 2011.Clin Infect Dis. 2021 Jun 15;72(12):e959-e969. doi: 10.1093/cid/ciaa1689. Clin Infect Dis. 2021. PMID: 33165566 Free PMC article. Clinical Trial.
-
Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design Studies.Open Forum Infect Dis. 2020 May 21;7(7):ofaa177. doi: 10.1093/ofid/ofaa177. eCollection 2020 Jul. Open Forum Infect Dis. 2020. PMID: 32704509 Free PMC article. Review.
References
-
- Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011;378(9807):1917–1930. PubMed PMID: 22078723. Epub 2011/11/15. eng. - PubMed
-
- Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151–2161. PubMed PMID: 22579125. Epub 2012/05/15. eng. - PubMed
-
- Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. The New England journal of medicine. 2006;355(1):31–40. PubMed PMID: 16822994. Epub 2006/07/11. eng. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
